569
Views
36
CrossRef citations to date
0
Altmetric
Original

IN VITRO MODELING OF HUMAN ALVEOLAR MACROPHAGE SMOKE EXPOSURE: ENHANCED INFLAMMATION AND IMPAIRED FUNCTION

, , , &
Pages 599-629 | Received 10 Apr 2008, Accepted 24 Jul 2008, Published online: 02 Jul 2009

REFERENCES

  • Lohmann-Matthes M L, Steinmuller C, Franke-Ullmann G. Pulmonary macrophages. Eur Respir J 1994; 7: 1678–1689
  • Geiser M. Morphological aspects of particle uptake by lung phagocytes. Microsc Res Tech 2002; 57: 512–522
  • Barnes P J. Alveolar macrophages as orchestrators of COPD. COPD: J Chron Obstruct Pulmon Dis 2004; 1: 59–70
  • Russell R E, Thorley A, Culpitt S V, Dodd S, Donnelly L E, Demattos C, Fitzgerald M, Barnes P J. Alveolar macrophage-mediated elastolysis: roles of matrix metalloproteinases, cysteine, and serine proteases. Am J Physiol Lung Cell Mol Physiol 2002; 283: L867–L873
  • Reynolds H Y. Use of bronchoalveolar lavage in humans-past necessity and future imperative. Lung 2000; 178: 271–293
  • Barnes P J. Alveolar Macrophages as Orchestrators of COPD. COPD: J Chron Obstruct Pulmon Dis 2004; 1: 59–70
  • Barnes P J. Mediators of chronic obstructive pulmonary disease. Pharmacol Rev 2004; 56: 515–548
  • Ito K, Lim S, Caramori G, Chung K F, Barnes P J, Adcock I M. Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. FASEB J 2001; 1110–1112
  • Culpitt S V, Rogers D F, Shah P, De Matos C, Russell R EK, Donnelly L E, Barnes P J. Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 167: 24–31
  • Cosio B G, Tsaprouni L, Ito K, Jazrawi E, Adcock I M, Barnes P J. Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages. J. Exp. Med 2004; 200: 689–695
  • Hodge S, Hodge G, Ahern J, Jersmann H, Holmes M, Reynolds P N. Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2007; 37: 748–755
  • Hodge S, Hodge G, Scicchitano R, Reynolds P N, Holmes M. Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells. Immunol Cell Biol 2003; 81: 289–296
  • Becker S, Warren M, Haskill S. Colony-stimulating factor-nduced monocyte survival and differentiation into macrophages in serum-free cultures. J Immunol 1987; 139: 3703–3709
  • Frendl G. Interleukin 3: from colony-stimulating factor to pluripotent immunoregulatory cytokine. Int J Immunopharmacol 1992; 14: 421–430
  • Young D A, Lowe L D, Clark S C. Comparison of the effects of IL-3, granulocyte-macrophage colony-stimulating factor, and macrophage colony-stimulating factor in supporting monocyte differentiation in culture. Analysis of macrophage antibody-dependent cellular cytotoxicity. J Immunol 1990; 145: 607–615
  • Akagawa K S. Functional heterogeneity of colony-stimulating factor-induced human monocyte-derived macrophages. Int J Hematol 2002; 76: 27–34
  • Metcalf D. The molecular biology and functions of the granulocyte-macrophage colony-timulating factors. Blood 1986; 67: 257–267
  • Geissler K, Harrington M, Srivastava C, Leemhuis T, Tricot G, Broxmeyer H. Effects of recombinant human colony stimulating factors (CSF) (granulocyte-macrophage CSF, granulocyte CSF, and CSF-1) on human monocyte/macrophage differentiation. J Immunol 1989; 143: 140–146
  • Stanley E R, Guilbert L J, Tushinski R J, Bartelmez S H. CSF-1-a mononuclear phagocyte lineage-specific hemopoietic growth factor. J Cell Biochem 1983; 21: 151–159
  • Tomokiyo R, Jinnouchi K, Honda M, Wada Y, Hanada N, Hiraoka T, Suzuki H, Kodama T, Takahashi K, Takeya M. Production, characterization, and interspecies reactivities of monoclonal antibodies against human class A macrophage scavenger receptors. Atherosclerosis 2002; 161: 123–132
  • Arredouani M S, Palecanda A, Koziel H, Huang Y C, Imrich A, Sulahian T H, Ning Y Y, Yang Z, Pikkarainen T, Sankala M, Vargas S O, Takeya M., Tryggvason K, Kobzik L. MARCO is the major binding receptor for unopsonized particles and bacteria on human alveolar macrophages. J Immunol 2005; 175: 6058–64
  • Stringer B, Imrich A, Kobzik L. Flow cytometric assay of lung macrophage uptake of environmental particulates. Cytometry 1995; 20: 23–32
  • Sulahian T H, Imrich A, Deloid G, Winkler A R, Kobzik L. Signaling pathways required for macrophage scavenger receptor-mediated phagocytosis: analysis by scanning cytometry. Respir Res Aug 7, 2008; 9: 59
  • Luppi F, Aarbiou J, van Wetering S, Rahman I, de Boer W I, Rabe K F, Hiemstra P S. Effects of cigarette smoke condensate on proliferation and wound closure of bronchial epithelial cells in vitro: role of glutathione. Respir Res 2005; 6: 140
  • Silver R F, Walrath J, Lee H, Jacobson B A, Horton H, Bowman M R, Nocka K, Sypek J P. Human Alveolar Macrophage Gene Responses to Mycobacterium tubercilosis Strains H37Ra and H37Rv. Am J Respir Cell Mol Biol Sep 11, 2008, [Epub ahead of print]
  • Woodruff P G, Koth L L, Yang Y H, Rodriguez M W, Favoreto S, Dolganov G M, Paquet A C, Erle D J. A distinctive alveolar macrophage activation state induced by cigarette smoking. Am J Respir Crit Care Med 2005; 172: 1383–1392
  • Alden T D, Pittman D D, Beres E J, Hankins G R, Kallmes D F, Wisotsky B M, Kerns K M, Helm G A. Percutaneous spinal fusion using bone morphogenetic protein-2 gene therapy. J Neurosurg 1999; 90: 109–114
  • Viksman M Y, Bochner B S, Peebles R S, Schleimer R P, Liu M C. Expression of activation markers on alveolar macrophages in allergic asthmatics after endobronchial or whole–lung allergen challenge. Clin Immunol 2002; 104: 77–85
  • Viksman M Y, Liu M C, Bickel C A, Schleimer R P, Bochner B S. Phenotypic analysis of alveolar macrophages and monocytes in allergic airway inflammation. I. Evidence for activation of alveolar macrophages, but not peripheral blood monocytes, in subjects with allergic rhinitis and asthma. Am J Respir Crit Care Med 1997; 155: 858–863
  • Lofdahl J M, Wahlstrom J, Skold C M. Different inflammatory cell pattern and macrophage phenotype in chronic obstructive pulmonary disease patients, smokers and non-smokers. Clin Exp Immunol 2006; 145: 428–437
  • Haugen T S, Skjonsberg O H, Nakstad B, Lyberg T. Modulation of adhesion molecule profiles on alveolar macrophages and blood leukocytes. Respiration 1999; 66: 528–37
  • Richeldi L, Mariani M, Losi M, Maselli F, Corbetta L, Buonsanti C, Colonna M, Sinigaglia F, Panina-Bordignon P, Fabbri L M. Triggering receptor expressed on myeloid cells: role in the diagnosis of lung infections. Eur Respir J 2004; 24: 247–50
  • Pons A R, Noguera A, Blanquer D, Sauleda J, Pons J, Agusti A G. Phenotypic characterisation of alveolar macrophages and peripheral blood monocytes in COPD. Eur Respir J 2005; 25: 647–652
  • Burke B, Sumner S, Maitland N, Lewis C E. Macrophages in gene therapy: cellular delivery vehicles and in vivo targets. J Leukoc Biol 2002; 72: 417–428
  • Di Nicola M, Carlo-Stella C, Milanesi M, Magni M, Longoni P, Mortarini R, Anichini A, Tomanin R, Scarpa M, Gianni A M. Large-scale feasibility of gene transduction into human CD34+ cell-derived dendritic cells by adenoviral/polycation complex. Br J Haematol 2000; 111: 344–50
  • Shapiro S D. The macrophage in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: 29S–32S
  • Ofulue A F, Ko M. Effects of depletion of neutrophils or macrophages on development of cigarette smoke-induced emphysema. Am J Physiol Lung Cell Mol Physiol 1999; 277: L97–L105
  • Landsman L, Jung S. Lung macrophages serve as obligatory intermediate between blood monocytes and alveolar macrophages. J Immunol 2007; 179: 3488–3494
  • Nicod L P. Pulmonary defence mechanisms. Respiration 1999; 66: 2–11
  • Tarling J, Lin H, Hsu S. Self-renewal of pulmonary alveolar macrophages: evidence from radiation chimera studies. J Leukoc Biol 1987; 42: 443–446
  • Murphy J, Summer R, Wilson A A, Kotton D N, Fine A. The prolonged life-span of alveolar macrophages. Am J Respir Cell Mol Biol 2008; 38: 380–385
  • Shibata Y, Zsengeller Z, Otake K, Palaniyar N, Trapnell B C. Alveolar macrophage deficiency in osteopetrotic mice deficient in macrophage colony-stimulating factor is spontaneously corrected with age and associated with matrix metalloproteinase expression and emphysema. Blood 2001; 98: 2845–2852
  • Bonfield T L, Raychaudhuri B, Malur A, Abraham S, Trapnell B C, Kavuru M S, Thomassen M J. PU.1 regulation of human alveolar macrophage differentiation requires granulocyte-macrophage colony-stimulating factor. Am J Physiol Lung Cell Mol Physiol 2003; 285: L1132–L1136
  • Reed J A, Ikegami M, Cianciolo E R, Lu W, Cho P S, Hull W, Jobe A H, Whitsett J A. Aerosolized GM-CSF ameliorates pulmonary alveolar proteinosis in GM-CSF-deficient mice. Am J Physiol Lung Cell Mol Physiol 1999; 276: L556–L563
  • Vlahos R, Bozinovski S, Hamilton J A, Anderson G P. Therapeutic potential of treating chronic obstructive pulmonary disease (COPD) by neutralising granulocyte macrophage-colony stimulating factor (GM-CSF). Pharmacol Therapeut 2006; 112: 106–115
  • Ritz S A, Stämpfli M R, Davies D E, Holgate S T, Jordana M. On the generation of allergic airway diseases: from GM–CSF to Kyoto. Trends Immunol 2002; 23: 396–402
  • Wahlstrom J, Berlin M, Skold C M, Wigzell H, Eklund A, Grunewald J. Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis. Thorax 1999; 54: 339–346
  • Nakstad B, Haugen T, Skjonsberg O, Lyberg T. Expression of leukocyte integrins and tissue factor in mononuclear phagocytes. Eur Respir J 1998; 12: 601–606
  • Ward C, Whitford H, Snell G, Bao H, Zheng L, Reid D, Williams T J, Walters E H. Bronchoalveolar lavage macrophage and lymphocyte phenotypes in lung transplant recipients. J Heart Lung Transplant 2001; 20: 1064–1074
  • Skold C M, Lundahl J, Hallden G, Hallgren M, Eklund A. Chronic smoke exposure alters the phenotype pattern and the metabolic response in human alveolar macrophages. Clin Exp Immunol 1996; 106: 108–113
  • Striz I, Wang Y M, Svarcova I, Trnka L, Sorg C, Costabel U. The phenotype of alveolar macrophages and its correlation with immune cells in bronchoalveolar lavage. Eur Respir J 1993; 6: 1287–1294
  • Nicod L P, Joudrier S, Isler P, Spiliopoulos A, Pache J-C. Upregulation of CD40, CD80, CD83 or CD86 on alveolar macrophages after lung transplantation. J Heart Lung Transplant 2005; 24: 1067–1075
  • Van d en, Heuvel M, Tensen C, van As J, Van den Berg T, Fluitsma D, Dijkstra C, Dopp E, Droste A, Van Gaalen F, Sorg C, Hogger P, Beelen R. Regulation of CD 163 on human macrophages: cross-linking of CD163 induces signaling and activation. J Leukoc Biol 1999; 66: 858–866
  • Porcheray F, Viaud S, Rimaniol A-C, Leone C, Samah B, Dereuddre-Bosquet N, Dormont D, Gras G. Macrophage activation switching: an asset for the resolution of inflammation. Clin Exp Immunol 2005; 142: 481–489
  • Lensmar C, Katchar K, Eklund A, Grunewald J, Wahlström J. Phenotypic analysis of alveolar macrophages and lymphocytes following allergen inhalation by atopic subjects with mild asthma. Respir Med 2006; 100: 918–925
  • Droemann D, Goldmann T, Tiedje T, Zabel P, Dalhoff K, Schaaf B. Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients. Respir Res 2005; 6: 68
  • Lin S-M, Frevert C W, Kajikawa O, Wurfel M M, Ballman K, Mongovin S, Wong V A, Selk A, Martin T R. (2004) Differential regulation of membrane CD14 expression and endotoxin-tolerance in alveolar macrophages. Am J Respir Cell Mol Biol 2004; 31: 162–170
  • Colonna M, Facchetti F. TREM-1 (triggering receptor expressed on myeloid cells): a new player in acute inflammatory responses. Journal of Infectious Diseases 2003; 187(Suppl 2)S397–S401
  • Maus U, Herold S, Muth H, Maus R, Ermert L, Ermert M, Weissmann N, Rosseau S, Seeger W, Grimminger F, Lohmeyer J. Monocytes recruited into the alveolar air space of mice show a monocytic phenotype but upregulate CD14. Am J Physiol Lung Cell Mol Physiol 2001; 280: L58–L68
  • Mochida-Nishimura K, Surewicz K, Cross J V, Hejal R, Templeton D, Rich E A, Toossi Z. Differential activation of MAP kinase signaling pathways and nuclear factor-kappaB in bronchoalveolar cells of smokers and nonsmokers. Mol Med 2001; 7: 177–85
  • Marwick J A, Kirkham P A, Stevenson C S, Danahay H, Giddings J, Butler K, Donaldson K, MacNee W, Rahman I. Cigarette smoke alters chromatin remodeling and induces proinflammatory genes in rat lungs. Am J Respir Cell Mol Biol 2004; 31: 633–642
  • Ferrara F, D'Adda D, Falchi M, Dall'Asta L. The macrophagic activity of patients affected by pneumonia or chronic obstructive pulmonary disease. Int J Tissue React 1996; 18: 109–114
  • Hodge S, Hodge G, Scicchitano R, Reynolds P N, Holmes M. Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells. Immunol Cell Biol 2003; 81: 289–296
  • Li J, Pritchard D K, Wang X, Park D R, Bumgarner R E, Schwartz S M, Liles W C. cDNA microarray analysis reveals fundamental differences in the expression profiles of primary human monocytes, monocyte-derived macrophages, and alveolar macrophages. J Leukoc Biol 2007; 81: 328–335

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.